Dr. Peter Marks, the former top FDA vaccine official who abruptly resigned from the regulator earlier this year, has joined Eli Lilly, the company confirmed Tuesday.
Lilly has named Marks the senior vice president of molecule discovery as well as the head of its infectious disease work. Lilly didn’t specify in an email to BioPharma Dive exactly what his duties will be in that role — the company is known for its obesity and diabetes medicines, as opposed to infectious disease research — but said that his appointment will become effective this month. The news was first reported by BioCentury.
“Lilly continually evaluates breakthrough science which could benefit patients,” a spokesperson said in an email. “[Marks’] expertise strengthens our abilities across multiple areas, both in our existing portfolio and in our work in emerging areas.”
Marks’ hiring…